Advanced Programme and Invitation to Register - IWA

08.30-09.0009.05-10.2009.05-09.2509.25-09.4509.45-10.05Wednesday, June 19HG F30: Adriano Joss, Switzerland, Source control and source separationChair: Kai UdertHG F30: Ecotox: Ecosystem Effects 2 HG F1: Source ControlHG F3: Oxidation processes 2Chairs: Laura Sigg,Chairs: Kai Udert,Chairs: Guiseppe Mascolo,Biomarker studies in fish as tools for health Separate treatment of hospital wastewater: Advanced oxidation processes: toxicity ofassessment of the Neckar river in the Mass balances, energy consumption and transformation products,Tübingen area,economic efficiency,Mestankova, Switzerland, IWA 11582Vincze, Germany IWA-11737Mauer, Germany, IWA-11657Fungi and the aquatic environment:occurrence, benefits and hurdles,Olivera, Portugal, IWA-11621-Occurrence and distribution characteristicsof pharmaceuticals in fish farm and marineenvironment, Oh, Korea, IWA-11556Electrochemical oxidation of personal careand household products in the aerobicallytreated grey water,Butkovskyi, Netherlands, IWA-11608Significance of aged care facilities as pointsources of micropollutants,Everding,Germany, IWA-1220610.05-10.20 Discussion10.20-10.50 Coffee break10.50-12.30HG F30: Biotransformation 2HG F1: Diffuse PollutionChairs: Kathrin Fenner,Chairs: Norihide Nakada; Christoph OrtFungal biodegradation of pharmaceuticals in Hydrogeological factors affecting PPCPshospital effluents,and PFCs in aquifers: Why the10.50-11.10 Badia Fabregat, Spain, IWA-11629concentrations of groundwater in Tokyocould be higher than those of secondaryeffluent? Japan, Kuroda, IWA-1171011.10-11.3011.30-11.5011.50-12.10Occurrence and Removal of the Free andConjugated Estrogens in Activated SludgeProcesses, Kumar, Japan, IWA-11601Biotransformation of Trace OrganicCompounds in an Open-Water Unit ProcessTreatment Wetland,Jasper, USA IWA-11754Understanding the removal mechanisms ofPPCPs and influence of main technologicalparameters applied in anaerobic UASB andaerobic CAS reactors,Alvarino, Spain, IWA-11769Associations of potential alternative tracerswith fecal indicator bacteria in tropical urbancatchments,Ekklesia, Singapore, IWA-11716Assessing cumulative water quality impactfrom onsite sewage systems using pharmaceuticalsand personal care products,Australien, Hamilton, IWA-11590Biocide emissions into urban waters - acomparison between two suburbancatchments,Denmark, Bollmann, IWA-11644Reductive and oxidative treatment ofpharmaceuticals and diagnostic agents -kinetic studies and verification oftransformation productsPutschev, Germany, IWA-11757Electrochemical removal of disinfection byproducts,Radjenovic, Australia, IWA-11721HG F3: PAC processesChairs: Christian Abegglen,Comparison of two PAC/UF processes forthe removal of micropollutants from wastewatertreatment plant effluent: processperformance and removal efficiency,Löwenberg, Switzerland, IWA-11637Low energy PAC-UF treatment formicropollutant removal from municipalwastewater,Corbaz, Switzerland, IWA-11682Enhancing the Efficiency of PowderedActivated Carbon for Micro PollutantRemoval by Immobilization in a Fixed Bed,Ruhl, Germany, IWA-11688High rate PAC reactor combined with OzoneOxidation for enhanced micro-pollutantsremoval from urban waste water;P. Sauvignet, France IWA-1178212.10-12.30 Discussion12.30-13.30 Lunch13.30-14.00HG F30: Michael Schärer, Switzerland, Micropollutants in municipal wastewater – from science to policyChair: Maria Fürhacker14.05-15.40HG F30: Biotransformation 3HG F1: Regulation/ManagementHG F3: GAC processesChairs: Walter Giger,Chair: Maria Fürhacker,Chair: Benedek Plόsz,Cometabolic biodegradation model of Assessment of Treatment Monitoring Evaluation of the role of adsorption andPharmaceutical and Personal Care Products(PPCPs) in nitrifying activated sludge Managing Indirect Potable Reuse,biological activated carbon filtration,Strategies for Groundwater Replenishment: biodegradation of micropollutants during14.05-14.25Carballa, Spain, IWA-11564Charrois, Australia, IWA 11573Rattier, Australia, IWA-1218014.25-14.4514.45-15.0515.05-15.25Investigating physiological limitations tomicrobial growth and chemical substrateutilization at low concentrations,Helbling, Switzerland, IWA-11749New insights into the nitration of phenolicmicro-contaminants in nitrifying activatedsludge, Jewell, IWA-11602Enantioselective Degradation of the ChiralHerbicide Beflubutamid in Soil,Bürge, Switzerland, IWA-11613Pharmaceuticals in the Aquatic Environment– From a Global Inventory of MeasuredEnvironmental Concentrations to Strategiesfor Action, Weber, Germany, IWA 11666Innovative chemical and biological tools forthe evaluation of the efficiency of wastewateradvanced treatments and sludge treatments,Capdeville, France, IWA-11680Health Related Indicator Value – TheGerman Approach to a first Assessment ofAnthropogenic Micropollutants,Eckhardt, Grummt, Germany, IWA-0235015.25-15.40 Discussion15.45-16.15 Closing remarks16.15 RefreshmentsBiological activated carbon process (BAC)for hazardous compound removal: modellingadsorption and bioregeneration,Lesage, France, IWA-11646Reduction of micropollutants using GranularActivated Carbon in an existing flocculationfilter on a municipal waste water treatmentplant in Düren, Germany,Benstöm, Germany, IWA-11640Adsorptive and oxidative elimination ofmicropollutants by the operation of "dynamicrecirculation" at Schwerte wastewater treatmentplant, Keysers, Germany, IWA-1172909.00-12.00Eawag, Dübendorf:Low energy building, experimentalhall, laboratoriesThursday, June 20: Technical visits starting from Eawag Chriesbach Forum at 9 amWWTP Neugut, DübendorfFull-scale ozonation plant afterbiological treatmentWater work Zürich: Full-scaleplant and Advanced oxidationpilot scale plant12.00-13.00 Sandwiches and Softdrinks at Eawag Chriesbach Forum13.00-16.00Eawag, Dübendorf:Low energy building, experimentalhall, laboratoriesWWTP Neugut, DübendorfFull-scale ozonation plant afterbiological treatmentWater work Zürich: Full-scaleplant and Advanced oxidationpilot scale plantWWTP Stockacher Aach,GermanyFull-scale PAC plant afterbiological treatment